Glioblastoma Pipeline Shifts to Biomarker-Guided Combination Therapies
A new Oncoscience perspective maps the 2025–2026 glioblastoma clinical trial pipeline across four mechanistic domains, showing how biomarker-guided selection and ...
A new Oncoscience perspective maps the 2025–2026 glioblastoma clinical trial pipeline across four mechanistic domains, showing how biomarker-guided selection and ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine